RSL Revolutionary Labs hosted an inspiring closing ceremony on Wednesday, July 5, 2023, at its headquarters, at the ASBIS High-tech Cluster conference facilities in Limassol to mark the successful conclusion of the mediSKIN entrepreneurship innovation project (SEED/0719/0200). The event, under the theme "It All Started with Compassion," served as a remarkable milestone, showcasing the power of compassion paired with innovation in the collaborative efforts of the project. Supported by the European Union's Recovery and Resilience Fund, the Republic of Cyprus, and the Research and Innovation Foundation, the project received funding of 498,000 euros under the call "Development of Internationally Competitive Innovaive Products and Services by STARTUPs (SEED)," enabling rapid development and promotion of competitive products in the international market.
The closing ceremony provided an opportunity to present and discuss the exceptional research and clinical results achieved throughout the mediSKIN project. It also unveiled a new line of innovative skincare products developed specifically to address the unique needs of oncology patients. Esteemed speakers, including Mr. Philippos Hadjizaharia, the Deputy Minister of Research, Innovation and Digital Policy, Mr. Theodoros Loucaides, the Director of the Research and Innovation Foundation, and Mr. Loucas Fourlas, Member of the European Parliament and President of MEPs Against Cancer, shared their profound insights and expressed unwavering support for this wonderful initiative.
The mediSKIN research project exemplifies the power of collaboration, bringing together three certified Cypriot innovative start-ups, namely RSL Revolutionary Labs Ltd, Promed Bioscience Ltd, and Theramir Ltd, alongside academic researchers from the Cyprus University of Technology and clinicians from the German Oncology Center. United by a shared vision and fueled by compassion and motivation to profoundly impact quality of life, the consortium partners worked to develop and commercialize a novel collagen-based formulation specifically designed to alleviate and prevent the undesirable side effects of cancer treatment.
During the ceremony, Prof. Dr. Marianna Prokopi-Demetriades, the scientific coordinator of the project and co-founder of RSL Revolutionary Labs Ltd, presented the project's concept, research and development results, and introduced the novel products. Clinical leaders Prof. Dr. Constantinos Zamboglou (Deputy Medical Director of the German Oncology Center) and Dr. Angelos Kassianos (Lecturer of the Nursing Department at Cyprus University of Technology) presented the preliminary clinical results and the clinical trial design, focusing on the assessment of the quality of life of oncology patients. Dr. Anna Christofini and Dr. Costas Pitsillides highlighted the milestones and key events during the project in their closing remarks.
The emotionally charged closing ceremony of the mediSKIN project celebrated not only its successful conclusion but also emphasized the profound impact of compassion in driving innovation. Renowned journalist Mr. Stavros Kyprianou, the event host, recognized the importance of such significant projects for the country, providing an opportunity to acknowledge and applaud the tireless efforts, unwavering dedication, and collective achievements of all the project contributors. Through the convergence of cuting-edge research, technological advancement, and genuine compassion for those affected by cancer, the mediSKIN project has made significant strides in improving the quality of life for patients undergoing treatment.
For more information, please contact:
RSL Revolutionary Labs
Contact Person: Maria Ioannou
Email: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра.
About RSL Revolutionary Labs:
RSL Revolutionary Labs is a dynamic and innovative start-up at the forefront of dermaceutical skin regeneration solutions. Our mission is to revolutionize the industry and make a positive impact on individuals' lives through groundbreaking advancements in skincare. Guided by compassion, we are dedicated to developing innovative products that enhance skin health and promote overall well-being. At RSL Revolutionary Labs, we believe in the power of innovation, empathy, and excellence. Our team of passionate experts is commited to pushing boundaries and delivering cuting-edge solutions that meet the unique needs of oncology patients. By combining scientific expertise with a deep understanding of patients’ needs, we strive to develop products that are both effective and transformative.
For more information about RSL Revolutionary Labs and our groundbreaking solutions, please visit our website at www.rsl-labs.com.
Photos: RSL Revolutionary Labs
